The proportion of patients taking a GLP-1 weight-loss drug following bariatric surgery increased substantially in recent years, although the timing of initiation after surgery varied widely, a large ...
New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?
Postoperative recurrent weight gain or suboptimal clinical response are important concerns; however, there is no consensus regarding the use of pharmacotherapy to manage weight after bariatric surgery ...
GLP-1 agonists are increasingly used post-bariatric surgery, with semaglutide being the most common, especially among younger, female, and Black or African American patients. The study highlights the ...
SAN ANTONIO — May 5, 2026 – Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of California San Diego find that GLP-1 prescriptions ...
New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic and bariatric surgery, signaling an evolution in the management of obesity and ...
New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic and bariatric surgery, signaling an evolution in the management of obesity and ...
THOMASVILLE — Archbold recently introduced da Vinci 5, the most powerful and fully integrated da Vinci system available. This advancement, the result of a decade of research, is designed to transform ...
Portneuf Medical Center has invited the community to get a hands-on look at robotic surgery during a Meet the Robot event ...
With the global prevalence of obesity steadily increasing, bariatric surgery has gained significance in managing this health challenge. Fast-track healthcare pathways have shown promise in improving ...
Rapid uptake of weight loss drugs before metabolic and bariatric surgery: Between 2020 and 2024, the use of weight loss drugs before surgery rose sixteenfold among metabolic and bariatric surgery ...